[go: up one dir, main page]

NO984740L - Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler - Google Patents

Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler

Info

Publication number
NO984740L
NO984740L NO984740A NO984740A NO984740L NO 984740 L NO984740 L NO 984740L NO 984740 A NO984740 A NO 984740A NO 984740 A NO984740 A NO 984740A NO 984740 L NO984740 L NO 984740L
Authority
NO
Norway
Prior art keywords
analgesics
compounds
acetylcholinesterase inhibitors
isatin derivatives
isatin
Prior art date
Application number
NO984740A
Other languages
English (en)
Other versions
NO984740D0 (no
Inventor
Stephen James Shimshock
Abdul Ezaz Mutlib
Susan Marie Chesson
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO984740D0 publication Critical patent/NO984740D0/no
Publication of NO984740L publication Critical patent/NO984740L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Foreliggende søknad angår forbindelser av formel (I) (D hvori R, X og Y er som definert, hvilke forbindelser er anvendbare for behand- ling av hukommelsesdysfunksjon som er karakterisert ved redusert cholinerg funksjon, og for analgesi, farmasøyt- iske preparater inneholdende forbindel- sene og metoder for fremstilling og anvendelse av forbindelsene.
NO984740A 1996-04-12 1998-10-09 Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler NO984740L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63187096A 1996-04-12 1996-04-12
PCT/US1997/003598 WO1997038993A1 (en) 1996-04-12 1997-03-07 Isatin derivatives as acetylcholinesterase inhibitors and analgesics

Publications (2)

Publication Number Publication Date
NO984740D0 NO984740D0 (no) 1998-10-09
NO984740L true NO984740L (no) 1998-10-09

Family

ID=24533114

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984740A NO984740L (no) 1996-04-12 1998-10-09 Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler

Country Status (19)

Country Link
EP (1) EP0892796B1 (no)
JP (1) JP4109718B2 (no)
KR (1) KR20000005379A (no)
CN (1) CN1215399A (no)
AR (1) AR006606A1 (no)
AT (1) ATE207483T1 (no)
BR (1) BR9708655A (no)
CA (1) CA2252039C (no)
DE (1) DE69707659T2 (no)
DK (1) DK0892796T3 (no)
ES (1) ES2165586T3 (no)
GR (1) GR3037006T3 (no)
HU (1) HUP9903473A3 (no)
IL (1) IL126308A0 (no)
NO (1) NO984740L (no)
PT (1) PT892796E (no)
TW (1) TW426678B (no)
WO (1) WO1997038993A1 (no)
ZA (1) ZA972990B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
JP5379692B2 (ja) 2006-11-09 2013-12-25 プロビオドルグ エージー 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体
EP2091948B1 (en) 2006-11-30 2012-04-18 Probiodrug AG Novel inhibitors of glutaminyl cyclase
EP2481408A3 (en) 2007-03-01 2013-01-09 Probiodrug AG New use of glutaminyl cyclase inhibitors
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
AU2010294214B2 (en) 2009-09-11 2015-05-07 Vivoryon Therapeutics N.V. Heterocylcic derivatives as inhibitors of glutaminyl cyclase
AU2011215870B2 (en) 2010-02-09 2016-01-28 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2536713A1 (en) 2010-02-16 2012-12-26 Pfizer Inc. (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
MX2012010470A (es) 2010-03-10 2012-10-09 Probiodrug Ag Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5).
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
HUE036280T2 (hu) 2012-12-13 2018-06-28 H Lundbeck As Vortioxetint és donepezilt tartalmazó készítmények
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
US11160785B2 (en) 2013-03-15 2021-11-02 Agenebio Inc. Methods and compositions for improving cognitive function
US10537552B2 (en) 2015-05-05 2020-01-21 Carafe Drug Innovation, Llc Substituted 5-hydroxyoxindoles and their use as analgesics and fever reducers
MX2017014774A (es) 2015-05-22 2018-02-15 Agenebio Inc Composiciones farmaceuticas de levetiracetam de liberacion extendida.
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296488A (en) * 1989-08-02 1994-03-22 Hoechst-Roussel Pharmaceuticals Inc. Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US4994472A (en) * 1989-08-02 1991-02-19 Hoechst-Roussel Pharmaceuticals Incorporated 1-(pyridinylamino)-2-pyrrolidinones as pain relievers

Also Published As

Publication number Publication date
TW426678B (en) 2001-03-21
CN1215399A (zh) 1999-04-28
ES2165586T3 (es) 2002-03-16
DK0892796T3 (da) 2001-11-19
DE69707659D1 (de) 2001-11-29
AU716997B2 (en) 2000-03-16
CA2252039C (en) 2002-12-24
BR9708655A (pt) 1999-08-03
JP4109718B2 (ja) 2008-07-02
NO984740D0 (no) 1998-10-09
WO1997038993A1 (en) 1997-10-23
IL126308A0 (en) 1999-05-09
ATE207483T1 (de) 2001-11-15
JP2001508400A (ja) 2001-06-26
AR006606A1 (es) 1999-09-08
PT892796E (pt) 2002-03-28
DE69707659T2 (de) 2002-05-08
AU2072597A (en) 1997-11-07
CA2252039A1 (en) 1997-10-23
EP0892796B1 (en) 2001-10-24
HUP9903473A2 (hu) 2000-05-28
HUP9903473A3 (en) 2000-09-28
GR3037006T3 (en) 2002-01-31
ZA972990B (en) 1997-11-03
EP0892796A1 (en) 1999-01-27
KR20000005379A (en) 2000-01-25

Similar Documents

Publication Publication Date Title
NO984740L (no) Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler
MX9702865A (es) Agentes estrogenicos.
BG106340A (en) Substituted oxoazaheterocyclyl compounds
WO2002046170A8 (en) Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
RU94036448A (ru) Производные галантамина и фармацевтическая композиция
AP9901478A0 (en) Compounds for the treatment of ischemia.
MY112413A (en) Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
AU2019502A (en) Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
NO20005714D0 (no) Nye substituerte cykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
BR0007589A (pt) Inibidores da proliferação de células
NO996108L (no) 9-oksinerytromycinderivater
NO20022558L (no) 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor
EA200101077A1 (ru) Композиция для профилактики или лечения слабоумия, включающая производное гидроксикоричной кислоты или экстракт растения рода angelicae, содержащий его
NO990896L (no) Bidentate metalloproteaseinhibitorer
DK0567271T3 (da) Steroidderivater til behandling af prostatahypertrofi, fremgangsmåde til fremstilling heraf og anvendelser heraf
NO984470L (no) Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase
WO2001072708A3 (en) OXINDOLE INHIBITORS OF FACTOR Xa
EG20726A (en) Process for preparing of galanthamine derivatives as acetylchol inc-sterase inhibitors
WO2001081316A3 (en) Substituted phenyl farnesyltransferase inhibitors
CA2266759A1 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
PT1044186E (pt) Composto 2-benzilamino-2-fenil-acetamida substituidos
NO983178L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasaytisk preparat for behandling eller profylakse av menopausesymptomer
EA200100090A3 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
NO975681L (no) Benzisoxazol- og indazol-derivater som antipsykotiske midler
DK0835868T3 (da) 2-aryl-3-aminoaryloxynaphthylforbindelser, mellemprodukter, sammensætninger og fremgangsmåder